2. Crude and adjusted associations with all-cause mortality and HF after-discharge according to quartiles of electrolyte variability independent of the mean.
| All-cause death (n = 4386) | Crude HR (95%CI) | P value | Model I HR (95%CI) | P value | Model II HR (95%CI) | P value | Model III HR(95%CI) | P value |
| Model I: adjusted for age and sex (n = 4386); Model II: adjusted for model 1 plus BMI, smoking, hypertension, diabetes, piror MI, cTnI, NTpro-BNP, CRP, eGFR, TG, TC, HDL, MI type, anterior MI, PCI, ACEI or ARB, spironolactone and acute heart failure (n = 4190). Model III: adjusted for model 1 plus mean potassium (n = 4190). ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; CI: confidence interval; cTnI: cardiac troponin I; CRP: C-reactive protein; eGFR: estimated glomerular filtration rate; HDL: high density lipoprotein; HF: heart failure; HR: hazards ratio; MI: myocardial infarction; NT-proBNP: N terminal pro B type natriuretic peptide; TC: total cholesterol; TG: triglycerides; PCI: percutaneous coronary intervention. | ||||||||
| K range per 1 mmol/L | 2.62 (2.10−3.27) | 0.000 | 2.43(1.95−3.03) | 0.000 | 1.69 (1.30−2.20) | 0.000 | 1.68 (1.29−2.19) | 0.000 |
| Na range per 5 mmol/L | 1.80 (1.54−2.10) | 0.000 | 1.66 (1.42−1.94) | 0.000 | 1.26 (1.05−1.50) | 0.013 | 1.26 (1.05−1.51) | 0.011 |
| K VIM quartiles | 0.000 | 0.000 | 0.004 | 0.003 | ||||
| Q1 | 1(ref.) | 1(ref.) | 1(ref.) | 1(ref.) | ||||
| Q2 | 2.19 (1.24−3.88) | 2.11 (1.19−3.74) | 1.69 (0.94−3.03) | 1.69 (0.94−3.03) | ||||
| Q3 | 2.41 (1.37−4.24) | 2.36 (1.34−4.14) | 1.59 (0.90−2.83) | 1.59 (0.89−2.82) | ||||
| Q4 | 3.52 (2.06−6.01) | 3.59 (2.10−6.13) | 2.30 (1.33−3.99) | 2.35 (1.36−4.06) | ||||
| Na VIM quartiles | 0.000 | 0.003 | 0.416 | 0.348 | ||||
| Q1 | 1(ref.) | 1(ref.) | 1(ref.) | 1(ref.) | ||||
| Q2 | 1.27 (0.77−2.10) | 1.18 (0.72−1.95) | 0.93 (0.56−1.55) | 0.94 (0.56−1.56) | ||||
| Q3 | 1.53 (0.94−2.48) | 1.39 (0.85−2.25) | 1.01 (0.61−1.66) | 1.02 (0.62−1.68) | ||||
| Q4 | 2.24 (1.42−3.54) | 1.91 (1.21−3.03) | 1.16 (0.72−1.86) | 1.19 (0.74−1.92) | ||||
| HF after-discharge | ||||||||
| K range per 1 mmol/L | 1.93 (1.68−2.22) | 0.000 | 1.86 (1.62−2.14) | 0.000 | 1.26 (1.07−1.48) | 0.005 | 1.27 (1.08−1.50) | 0.004 |
| Na range per 5 mmol/L | 1.56 (1.42−1.72) | 0.000 | 1.49 (1.36−1.64) | 0.000 | 1.16 (1.04−1.29) | 0.009 | 1.16 (1.04−1.30) | 0.008 |
| K VIM quartiles | 0.000 | 0.000 | 0.051 | 0.051 | ||||
| Q1 | 1(ref.) | 1(ref.) | 1(ref.) | 1(ref.) | ||||
| Q2 | 1.48 (1.13−1.93) | 1.45 (1.11−1.89) | 1.22 (0.93−1.61) | 1.22 (0.93−1.61) | ||||
| Q3 | 1.73 (1.34−2.25) | 1.72 (1.33−2.23) | 1.27 (0.97−1.67) | 1.27 (0.97−1.67) | ||||
| Q4 | 1.99 (1.55−2.57) | 2.02 (1.56−2.60) | 1.32 (1.01−1.72) | 1.32 (1.01−1.72) | ||||
| Na VIM quartiles | 0.000 | 0.000 | 0.040 | 0.038 | ||||
| Q1 | 1(ref.) | 1(ref.) | 1(ref.) | 1(ref.) | ||||
| Q2 | 1.26 (0.96−1.64) | 1.21 (0.93−1.58) | 1.01 (0.77−1.34) | 1.02 (0.77−1.34) | ||||
| Q3 | 1.58 (1.22−2.04) | 1.51 (1.17−1.95) | 1.17 (0.90−1.53) | 1.18 (0.90−1.54) | ||||
| Q4 | 2.03 (1.59−2.60) | 1.87 (1.46−2.39) | 1.25 (0.97−1.63) | 1.26 (0.97−1.64) | ||||